Furthermore, increased PPP1CC and FYN expression was correlated with increased drug sensitivity to cancer cells, such as PX−316, Ifosfamide, okadaic acid, Chelerythrine, AT-13387, and Amonafide (cor > 0.29 and P < 0.05). The gene discussed is PPP1CC; the disease is cancer.